Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Systemic Mastocytosis and Other Entities Involving Mast Cells: A Practical Review and Update. | Cancers (Basel) | 2022 | 35884535 | PubTator, text mining | PubMed |
| Inhibition of NEDD8 NEDDylation induced apoptosis in acute myeloid leukemia cells via p53 signaling pathway. | Biosci Rep | 2022 | 35880551 | PubTator, text mining | PubMed |
| Comparative evaluation of the developed targeted RNA sequencing system and a commercialized test panel. | Blood Res | 2022 | 35880497 | PubTator, text mining | PubMed |
| Development and validation of a prognostic scoring model to risk stratify childhood acute myeloid leukaemia. | Br J Haematol | 2022 | 35880261 | PubTator, text mining | PubMed |
| The first Japanese biobank of patient-derived pediatric acute lymphoblastic leukemia xenograft models. | Cancer Sci | 2022 | 35879192 | PubTator, text mining | PubMed |
| Large-Scale In Vitro and In Vivo CRISPR-Cas9 Knockout Screens Identify a 16-Gene Fitness Score for Improved Risk Assessment in Acute Myeloid Leukemia. | Clin Cancer Res | 2022 | 35877119 | PubTator, text mining | PubMed |
| Clinical Characteristics and Treatment Outcomes of Myeloid Sarcoma in Children: The Experience of the Polish Pediatric Leukemia and Lymphoma Study Group. | Front Oncol | 2022 | 35875115 | PubTator, text mining | PubMed |
| Characteristics, Treatment Complexity, and Outcome of Mixed-Phenotype Acute Leukemia in Children in a Low-Middle-Income Country. | Front Oncol | 2022 | 35875063 | PubTator, text mining | PubMed |
| Low IL7R Expression at Diagnosis Predicted Relapse in Adult Acute Myeloid Leukemia Patients With t(8;21). | Front Immunol | 2022 | 35874754 | PubTator, text mining | PubMed |
| Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells. | Front Oncol | 2022 | 35865470 | PubTator, text mining | PubMed |
| A Case of Chronic Myelomonocytic Leukemia Unmasked After Receiving J&J COVID-19 Vaccine. | Cureus | 2022 | 35865440 | PubTator, text mining | PubMed |
| Unified gene expression signature of novel NPM1 exon 5 mutations in acute myeloid leukemia. | Blood Adv | 2022 | 35849707 | PubTator, text mining | PubMed |
| DNA methyltransferase-1 in acute myeloid leukaemia: beyond the maintenance of DNA methylation. | Ann Med | 2022 | 35838271 | PubTator, text mining | PubMed |
| Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer. | J Clin Lab Anal | 2022 | 35837987 | PubTator, text mining | PubMed |
| KDM4 inhibitor SD49-7 attenuates leukemia stem cell via KDM4A/MDM2/p21CIP1 axis. | Theranostics | 2022 | 35836814 | PubTator, text mining | PubMed |
| A Novel BRD Family PROTAC Inhibitor dBET1 Exerts Great Anti-Cancer Effects by Targeting c-MYC in Acute Myeloid Leukemia Cells. | Pathol Oncol Res | 2022 | 35832114 | PubTator, text mining | PubMed |
| EAHP 2020 workshop proceedings, pediatric myeloid neoplasms. | Virchows Arch | 2022 | 35819517 | PubTator, text mining | PubMed |
| Leukemic Stem Cell: A Mini-Review on Clinical Perspectives. | Front Oncol | 2022 | 35814466 | PubTator, text mining | PubMed |
| The trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine inhibits lipopolysaccharide-induced inflammation transcriptomic pathways and cytokine secretion in a macrophage cell model. | Toxicol In Vitro | 2022 | 35811015 | PubTator, text mining | PubMed |
| In Vitro and In Vivo Modeling of Normal and Leukemic Bone Marrow Niches: Cellular Senescence Contribution to Leukemia Induction and Progression. | Int J Mol Sci | 2022 | 35806354 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=34